Individualized Homoeopathy vs Standard care in management of Chronic Obstructive Pulmonary Disease

Effectiveness of Individualized Homoeopathy vs Standard care in the Management of Chronic Obstructive Pulmonary Disease: A Multicentric Randomized Controlled Trial - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/02/080566

Enrollment

240

Registered

2025-02-14

Start date

Unknown

Completion date

Unknown

Last updated

2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J449- Chronic obstructive pulmonary disease, unspecified

Interventions

Intervention1: Homoeopathy: Individualized Homeopathic medicines will be given. The dose of the medicine will be in centesimal potency in the form of globules (4 globules/dose). Frequency of the medic

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed cases of COPD. FEV1 FVC ratio less than 0.7. FEV1 greater than 50%. Patients presenting with chronic cough with excessive mucopurulent expectoration for at least 3 months in a year for more than two consecutive years. Patients willing to participate in the study.

Exclusion criteria

Exclusion criteria: Patients suffering from other respiratory diseases like bronchial asthma, active pulmonary tuberculosis, broncho-pulmonary mycosis, cor-pulmonale, acute bronchitis, pulmonary thromboembolism, pulmonary hypertension, bronchiectasis, Sarcoidosis, congestive cardiac failure etc. FEV1 less than 50% Persons requiring hospitalization with other co-morbid conditions. Persons requiring oxygen therapy and hospitalization. Persons not willing to provide consent for the study. History of recent steroid and antibiotics intake (within last 4 weeks). Pregnant and Lactating mothers

Design outcomes

Primary

Measure	Time frame
To assess effectiveness of homoeopathic medicines vs standard care in the management of COPD through COPD assessment test (CAT) scoreTimepoint: Primary Outcome will be evaluated every month for 1 year. Assesment will be done after completion of study at 1 year.	—

Secondary

Measure	Time frame
1.To compare changes in FEV1 FVC Ratio, FEV1 & FVC values in both the groups through spirometry. 2.To compare changes in the number of COPD exacerbations in both the groups (through measuring FDI of episodes each month) Timepoint: Secondary Outcome will be evaluated every month for 1 year. Assessment will be done after completion of study at 1 year	—

Countries

India

Contacts

Public ContactDr Bharti Wadhwa

Central Council for Research in Homoeopathy

bhartiwadhwa@gmail.com09818262049

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026